4 resultados para Private Copying

em Université de Montréal, Canada


Relevância:

60.00% 60.00%

Publicador:

Resumo:

Le présent article vise à exposer la situation du régime de la copie privée face à Internet, tant dans son application que dans sa légitimité. L’auteur soumet notamment que l’exception de la copie privée n’est applicable ni à la mise à disposition ni au téléchargement de fichiers musicaux sur Internet à moins que, quant à ce dernier acte, la copie provienne d’une source licite, ce qui exclut les réseaux peer-to-peer. Ensuite, l’auteur analyse la question quant à savoir si les enregistreurs audionumériques et les disques durs des ordinateurs personnels devraient être soumis aux redevances au Canada, et conclut à l’effet qu’une réforme de la Loi sur le droit d’auteur est de mise si l’on veut en arriver à une telle éventualité. Finalement dans la dernière partie, l’auteur soulève la question de la remise en cause du régime de la copie privée face à l’importance grandissante que l‘on accorde à la gestion numérique des droits.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

This paper examines a characteristic of common property problems unmodeled in the published literature: Extracted common reserves are aften stored privately rather than immediately. We examine the positive and normative effects of such storage.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Genetic testing technologies are rapidly moving from the research laboratory to the market place. Very little scholarship considers the implications of private genetic testing for a public health care system such as Canada’s. It is critical to consider how and if these tests should be marketed to, and purchased by, the public. It is also imperative to evaluate the extent to which genetic tests are or should be included in Canada’s public health care system, and the impact of allowing a two-tiered system for genetic testing. A series of threshold tests are presented as ways of clarifying whether a genetic test is morally appropriate, effective and safe, efficient and appropriate for public funding and whether private purchase poses special problems and requires further regulation. These thresholds also identify the research questions around which professional, public and policy debate must be sustained: What is a morally acceptable goal for genetic services? What are the appropriate benefits? What are the risks? When is it acceptable that services are not funded under health care? And how can the harms of private access be managed?